medigraphic.com
Órgano Oficial de la Asociación Mexicana de Infectología Pediátrica y la SLIPE.

2013, Número 106

<< Anterior Siguiente >>

Rev Enfer Infec Pediatr 2013; 26.27 (106)


Choque séptico por Vibrio vulnificus: reporte de un caso en pediatría

Fonseca FM. Lizárraga LSL. De Colsa RA

Idioma: Español
Referencias bibliográficas: 25
Paginas: 377-383
Archivo PDF: 405.87 Kb.


RESUMEN

Los reportes de infección por V. vulnificus en pediatría son limitados en la literatura, y característicamente se describen 3 cuadros clínicos: Sepsis Primaria, Infección de piel y tejidos blandos e Infección gastrointestinal. Se reporta el caso de un paciente masculino de 15 años de edad con diagnóstico de aplasia pura de serie roja y hemosiderosis, quien ingresa con cuadro febril, lesiones dérmicas, diarrea y datos de choque. A los 4 días de su ingreso se identifica Vibrio vulnificus en hemocultivo, sin embargo, el paciente fallece a pesar del tratamiento establecido. Con la presentación de este caso, se describen las características clínicas, epidemiológicas, factores de riesgos y evolución de la infección sistémica por V. vulnificus.


REFERENCIAS (EN ESTE ARTÍCULO)

  1. Angulo FJ. Vibrio vulnificus Oysters: pearls and perils. Clin Infect Dis. 2011; 52(6): 788-792.

  2. Shapiro RL, Altekruse S, Hutwagner L, et al. The role of Gulf Coast oysters harvested in warmer months in Vibrio vulnificus infections in the United States, 1988-1996. J Infect Dis. 1998; 178: 752-9.

  3. Centers for Disease Control and prevention. Vibrio vulnificus general information. Atlanta, GA: CDC 2009. Disponible en: http://www.cdc.gov/nczved/divisions/dfbmd/diseases/ vibriov/ (Último acceso: 05 Marzo, 2013).

  4. Oliver JD. Wound infections caused by Vibrio vulnificus and other marine bacteria. Epidemiol Infect. 2005; 133: 383-91.

  5. Strom MS, Paranjpye RN. Epidemiology and pathogenesis of Vibrio vulnificus. Microbes Infect. 2000; 2: 177-88.

  6. Motes ML, DePaola A, Cook DW, Veazey JE, Hunsuler JC, Garthright WE, et al. Influence of water temperature and salinity on Vibrio vulnificus in Northern Gulf and Atlantic Coast Oysters (Crassostrea virginica). Appl Environ Microbiol. 1998; 64: 1459-65.

  7. Zaidestein R, Sadik C, Lerner L, Valinsky L, Kopelowitz J, Yishai R, et al. Clinical characteristics and molecular subtyping of Vibrio vulnificus illnesses, Israel. Emerg Infect Dis. 2008; 14: 1875-82.

  8. Roland FP. Leg gangrene and endotoxin shock due to Vibrio parahaemolyticus an infection acquired in New England Coasts Waters. N Eng J Med. 1970; 1282-1306.

  9. Dechet AM, Yu PA, Koram N, Painter J. Nonfoodborne Vibrio infections: an important cause of morbidity and mortality in the United States, 1997-2006. Clin Infect Dis. 1996; 173: 1176-83.

  10. Haq SM, Dayal HH. Chronic liver disease and consumption of raw oysters: a potentially lethal combination- a review of Vibrio vulnificus septicemia. Am J Gastroenterol. 2005; 100: 1195-9.

  11. Kim JS, Choi SH, Lee JK. Lysine decarboxylase expression by Vibrio vulnificus is induced by SoxR in response to superoxide stress. J Bacteriol. 2006; 188: 8586-92.

  12. Kang IH, Kim JS, Lee JK. The virulence of Vibrio vulnificus is affected by the cellular level of superoxide dismutase activity. J Microbiol Biotechnol. 2007; 17: 1399-402.

  13. Kim JS, Sung MH, Kho DH, Lee JK. Induction of manganese- containing superoxide dismutase is required for acid tolerance in Vibrio vulnificus. J Bacteriol. 2005; 187: 5984-95.

  14. Powell JL, Strauss KA, Wiley C, Zhan M, Morris Jr JG. Inflammatory cytokine response to Vibrio vulnificus elicited by peripheral blood mononuclear cells from chronic alcohol users is associated with biomarkers of cellular oxidative stress. Infect Immun. 2003; 71: 4212-6.

  15. Shin SH, Shin DH, Ryu PY, Chung SS, Rhee JH. Proinflammatory cytokine profile in Vibrio vulnificus septicemic patient´s sera. FEMS Immunol Med Microbiol. 2002; 33: 133-8.

  16. Powell JL, Wright AC, Wasserman SS, Hone DM, Morris Jr JG. Release of tumor necrosis factor alpha in response to Vibrio vulnificus capsular polysaccharide in vivo and in vitro models. Infect Immun. 1997; 65: 3713-8.

  17. Jones MK, Oliver JD. Vibrio vulnificus: disease and pathogenesis. Infect Immun. 2009; 77: 1723-33.

  18. Musher DM, Hansen MV, Goree A, Gyorkey F, Chapman AJ, Baughn RE. Emergence of bactericidal and opsonizing antibody to Vibrio vulnificus following bacterial infection. J Clin Microbiol. 1986; 23: 411-5.

  19. Gulig PA, Bourdage KL, Starks AM. Molecular pathogenesis of Vibrio vulnificus. J Microbiol. 2005; 43 Spec No: 118-31.

  20. Horseman MA, Surani S. A comprehensive review of Vibrio vulnificus: an important cause of severe sepsis and skin and soft-tissue infection. Int J Infect Dis. 2011; 15: e157-e166.

  21. Nakafusa J, Misago N, Miura Y, Kayaba M, Tanaka T, Narisawa Y. The importance of serum creatine phosphokinase level in the early diagnosis, and as a prognostic factor, of Vibrio vulnificus infection. Br J Dermatol. 2001; 145: 280-4.

  22. Kiontz KC, Lieb S, Schreiber M, Janowski HT, Baldy LM, Gunn RA. Syndromes of Vibrio vulnificus infections: clinical and epidemiologic features in Florida cases, 1981-1987. Ann Intern Med. 1988; 109: 318-23.

  23. Heymann, DL, ed. Control of Communicable Diseases Manual. 18th ed. Washington, DC: American Public Health Association; 2004.

  24. Chen SC, Lee YT, Tsai SJ, Chan KS, Chao WN, Wang PH, Lin DB, Chen CC, Lee MC. Antibiotic therapy for necrotizing fasciitis caused by Vibrio vulnificus: retrospective analysis of an 8 year period. J Antimicrob Chemother. 2012; 67: 488–493.

  25. Matsuoka Y, Nakayama Y, Yamada T, Nakagawachi A, Matsumoto K, Nakamura K, Sugiyama K, Tanigawa Y, Kakiuchi Y, Sakaguchi Y. Accurate diagnosis and treatment of Vibrio vulnificus infection: a retrospective study of 12 cases. Braz J Infect Dis. 2013; 17(1): 7-12.




2020     |     www.medigraphic.com